SEC Form 4 · accession 0001104659-18-039453
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael A Zasloff
Director
Period of report
Jun 7, 2018
Accepted (ET)
Jun 11, 2018 · 8:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 7, 2018 | A | 6,590 | $0.00 | A | 44,845 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $16.69 | Jun 7, 2018 | A | 16,679 | A | — | Jun 7, 2026 | Common Stock | 16,679 | 16,679 | D |
Explanation of responses
- F1`The reported shares are represented by restricted stock units, or RSUs, which vest in two equal annual installments beginning on June 7, 2019.
- F2Shares subject to the option vest in two equal annual installments beginning on June 7, 2019.
Remarks
Exhibit 24 - Power of Attorney